Sage Journals: Discover world-class research

Abstract

Background

Exercise therapy is an important treatment option for people with intermittent claudication (IC). Appropriate reporting of exercise interventions in populations with IC within randomised controlled trials (RCTs) is important to ensure that research can be translated into clinical practice. Therefore, the purpose of our review is to evaluate the reporting of exercise interventions in RCTs of exercise therapy in patients with IC.

Methods

A systematic search was performed to identify relevant trials in patients with IC published until May 2020. Studies including only participants with critical limb ischaemia or asymptomatic peripheral artery disease were excluded. Each trial was scored using the recently developed ‘Consensus on Exercise Reporting Template’ (CERT) which has a maximum obtainable score of 19.

Results

Of 1489 unique records identified from the search, 73 trials were included, reporting 107 exercise interventions. Overall, the average CERT score was 10/19. The exercise equipment used, the use of supervision and a description of whether the exercise prescription was tailored or generic were the most frequently reported intervention components. The motivational strategies used, intervention adherence and intervention fidelity were the most underreported CERT components. There was no trend indicating that CERT scores were higher in more recent publications.

Conclusions

We have identified that important details about exercise interventions are frequently missing from the published literature. These missing data hinder replication of research findings and limit the translation of evidence into clinical practice.

Keywords

Intermittent claudication systematic review exercise exercise therapy

Introduction

Peripheral arterial disease (PAD) is characterised by atherosclerosis of the arteries supplying the lower limbs, resulting in a reduced blood supply. The prevalence of PAD is estimated to have increased by 23.5% between 2000 and 2010¹ with current estimates at 237 million people affected globally.² Around 20–25% of individuals over 60 years old experience symptoms from PAD,³ most commonly intermittent claudication (IC). IC is a reproducible leg pain or discomfort that manifests during physical exertion, typically walking, and is relieved by rest. IC has deleterious effects on quality of life and is associated with an increased mortality risk.⁴

A first-line treatment for IC is exercise therapy, a prescription of regular supervised exercise to improve quality of life via improvements in walking performance. The efficacy of exercise therapy for improving walking performance is supported by Level 1A evidence.⁵ As such, supervised exercise training is recommended for the management of IC by the European Society for Vascular Surgery and European Society of Cardiology,⁶ the UK National Institute for Health and Care Excellence⁷ and the American Heart Association.⁸

Notwithstanding evidence supporting the efficacy of exercise therapy in clinical trials, its effectiveness (i.e. real-world treatment effect) is less clear. Shortcomings with service provision,^9,10 programme uptake and adherence¹¹ are amongst the known factors that have limited the effectiveness of simply recommending exercise therapy. Despite this, how it is implemented in practice is poorly understood, precluding the advancement of practical guidance. Current guidance is based on highly heterogenous literature in terms of the treatment context, healthcare professional training/discipline, population characteristics and exercise prescription - the frequency, intensity, time and type of exercise which together constitute the dose of exercise received.¹² Whilst it is encouraging that in a pooled analysis, exercise has a meaningful benefit in this population, there remains a challenge for distilling knowledge about how to optimally provide this key treatment.

Very few published studies have evaluated the effectiveness of exercise programmes in routine care. Underlying this is the reality that exercise therapy is a complex intervention; multiple components within an exercise prescription interact to achieve an effective exercise dose which must be sustained for an adequate period to achieve the desired therapeutic effect. Exercise interventions therefore require detailed descriptions to enable efficacious research protocols to be faithfully implemented in practice and to inform robust evaluations of exercise services.

To understand and reliably reproduce the effects of an exercise protocol used in a trial, sufficient detail regarding how the intervention was conducted must be provided. Therefore, this review aimed to evaluate the quality of reporting of published exercise interventions used to treat IC in randomised controlled trials (RCTs). Collating the components of published exercise interventions also will allow us to clarify the inferences that can be made from available data about exercise programming and prescription for people with IC. This will enable us to identify future research priorities in this field.

Methods

This review was conducted in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidance.¹³

Search strategy

Four databases, CINAHL, Medline, EMBASE and Cochrane CENTRAL, were searched from 1995 to May 2020. In addition, five existing systematic reviews and meta-analyses were manually searched to identify other trials eligible for inclusion.^5,14–17 Only studies published in the English language and relating to adults with IC (over 18 years of age) were included. Titles and abstracts were independently interrogated for inclusion by two reviewers (SB and SP) and disagreements resolved by discussion. The full text of any potentially eligible article was then screened against the inclusion and exclusion criteria. Full search strategies can be found in Supplementary material 1.

Eligible articles

We included prospective RCTs where patients with IC (typical and atypical) were randomised to at least one arm that included a structured supervised or unsupervised exercise programme. We defined a structured exercise training programme as one that stated the prescribed frequency, intensity and/or duration. No limits were placed on the type or duration of the exercise intervention. We elected to exclude studies that were published prior to 1995 as the majority of exercise programmes published after this date were designed using the recommendation of a specific meta-analysis.¹⁸ Studies including patients with critical limb ischaemia or asymptomatic PAD were also excluded.

Outcomes

To assess the quality of the reporting of the exercise intervention used in these trials, the ‘Consensus on Exercise Reporting template’ (CERT) was used.¹⁹ The CERT was developed and endorsed by an international panel of experts to allow a standardised appraisal of published exercise rehabilitation interventions. It comprises a 16-item checklist that was designed to evaluate the completeness of reporting of exercise descriptions and spans the ‘who’, ‘what’, ‘when’, ‘where’ and ‘how’ of exercise interventions. We utilised the CERT ‘Explanation and Elaboration Statement’ to inform scoring.¹⁹ Each item of the CERT was scored as a binary outcome (adequately reported vs inadequately reported, unclear or not reported at all) with a maximum possible score of 19.

Data extraction

Five assessors (SI, SB, EC, SP and AH) independently reviewed and extracted data using a standardised, purpose-built database. Where a study included more than one intervention arm which involved exercise, data were extracted for each arm and the individual intervention was evaluated rather than only the study. Extraction for each study was cross checked for accuracy and completeness by two reviewers (SI and AH). Data extraction included study characteristics, sample size, description of exercise prescription according to the ‘FITT principle’ (frequency, intensity, time and type of exercise performed) and information related to each CERT item.¹⁹ In addition, whilst the first CERT item considers whether a description of the exercise equipment is provided, we also recorded whether the make or model of equipment was reported, but this did not contribute to the overall CERT score. Where applicable, we consulted additional study sources (i.e. protocols and supplementary materials) to aid scoring.

Data synthesis

A narrative synthesis of the reporting of exercise interventions was performed. Intervention content was summarised by item according to the CERT checklist and FITT descriptors. To examine the change in intervention reporting quality over time, a Spearman correlation coefficient was calculated between the year of study publication and a study’s CERT score. Alpha was accepted as p < 0.05.

Results

Database searches identified 1489 unique records. Of these, 73 trials, comprising 107 exercise interventions, met the²⁰ inclusion criteria and were ultimately included in this review (Figure 1).^21–87

Figure 1.

PRISMA flow diagram.

Consensus on exercise reporting template score

A summary of the scores for each CERT item is provided in Figure 2. The mean CERT score was 10 ± 3 out of a possible 19. The CERT score for each intervention is displayed in Figure 3. Only 28% of interventions scored more than 11/19. There was no difference between the CERT scores in the 11 studies published after the CERT guidance was released and those that pre-dated the CERT (11.3 ± 3.3 vs 9.9 ± 3.2; p = 0.127). There was no relationship between year of publication and CERT score (ρ = 0.14, p = 0.14, Supplemental Figure 1).

Question 1: Detailed description of the type of exercise equipment.

Figure 2.

Reporting standards by individuals question of the Consensus on Exercise Reporting Template (CERT) in exercise interventions to treat intermittent claudication.

Figure 3.

Reporting standards by intervention for the Consensus on Exercise Reporting Template (CERT) in exercise interventions to treat intermittent claudication. For studies that have multiple exercise intervention arms the intervention being scored has been disambiguated.

The mode of exercise performed was typically described with an indication of the type of equipment used (if any) such as a treadmill or Nordic walking poles. However, only 36% of studies that described the use of equipment gave specific details of the make or model used.

Question 2: Detailed description of the qualifications, expertise and/or training.

Less than half (47%) of the included interventions provided a description of the qualifications, profession and/or training of those delivering the exercise intervention. A variety of professions were described including physiotherapists (most common), vascular nurses, research nurses, exercise physiologists, exercise instructors, rehabilitation assistants, vascular technologists and research assistants.

Question 3: Describe whether exercises are performed individually or in a group.

Information regarding whether interventions were delivered in a group or individually was limited, with only 34% of interventions providing this specific information.

Question 4: Describe whether exercises are supervised or unsupervised; how they are delivered.

The vast majority (94%) of interventions reported the level of supervision provided in each intervention.

Question 5: Detailed description of how adherence to exercise is measured and reported.

Few interventions (33%) provided a description of how they defined adherence to the intervention. If adherence was measured, it was typically via self-reported activity logs or records of attendance to supervised sessions.

Question 6: Detailed description of motivation strategies.

Very few interventions (15%) described the use of behavioural or motivational strategies to support adherence to the intervention. Examples include providing information about the benefits of exercise via written materials or having weekly telephone contact with a nurse or exercise professional who provided support adhere to the intervention.

Question 7a: Detailed description of the decision rule(s) for determining exercise progression; Question 7b: Detailed description of how the exercise programme was progressed.

A decision rule determining how the dose of exercise would be progressed based on an individuals’ performance was provided in less than half of the interventions (47%); for example, increasing the speed or elevation of a treadmill when a participant walked for 8 min without reaching moderate pain. Occasionally, a general rule for exercise dose progression was employed irrespective of individual performance, such as increasing the duration of walking in a session by 5 min every 2 weeks. Accordingly, descriptions of how exercise was progressed were better reported (69%). Progression was typically made by increasing the exercise intensity (e.g. the speed or gradient of treadmill walking) or total duration.

Question 8: Detailed description of each exercise to enable replication.

An adequate description of the exercises that made up the intervention that would enable replication was provided in most instances (87%). However, it was noted that many instructions were imprecise and could be interpreted and implemented in various ways. For example, where multiple exercises were used within an intervention, it was often unclear how vigorous an effort one should make for different exercises, whether the order of exercises was fixed or variable, or whether rest periods were used within or between exercise bouts.

Question 9: Detailed description of any home programme component.

Half of the interventions described a home-based component such as completing the entire programme at home or supplementing centre-based activities with unsupervised walking in another setting of the participant’s choosing.

Question 10: Describe whether there are any non-exercise components.

Additional intervention components such as the provision of written or verbal advice regarding diet, weight loss, physical activity or smoking cessation were infrequently reported (28%). Other examples include specification of the standard of medical care in study participants such as the provision of antiplatelet and lipid-lowering therapies.

Question 11: Describe the type and number of adverse events that occurred during exercise.

Reporting of adverse events was low (37%). Most studies that commented on adverse events stated that none occurred. In some instances, only unanticipated or serious adverse events were reported. Of the studies that reported adverse events, most did not specify whether an adverse event was related to the intervention - only one related event was reported (musculoskeletal injury). Other instances of adverse events were not adequately described to identify whether they were caused by the intervention.

Question 12: Describe the setting in which the exercises are performed.

Less than half of the interventions (47%) described the environment (gym, laboratory, outdoors, etc.) where exercise was performed.

Questions 13: Detailed description of the exercise intervention; 14a: Describe whether the exercises are generic (one-size-fits-all) or tailored; 14b: Detailed description of how exercises are tailored to the individual.

Most studies provided a detailed description of the exercise intervention (88%) and provided information as to whether the exercise prescription was generic or individually tailored (95%). Only 60% of interventions provided a detailed description of how exercise was individually tailored.

Question 15: Describe the decision rule for determining the starting level.

Only 47% of interventions described a decision rule that was used to determine the initial exercise dose prescribed to a participant, such as walking at 75% of the workload achieved on a treadmill test.

Question 16a: Describe how adherence or fidelity is assessed/measured; 16b: Describe the extent to which the intervention was delivered as planned.

It was rarely reported (17%) that adherence to the intervention was assessed. In most instances, where fidelity was considered, the limited definition of attendance to training sessions was used. This assumes that the delivery of exercise during sessions is perfect or very consistent. Only 32% of interventions reported that they were delivered as planned - either in writing or via reported data.

Frequency, intensity, time and type of exercise performed descriptors

Frequency

The most common exercise frequency was 3 times per week (49/107); followed by daily exercise (29/107); two sessions per week (23/107); one session per week (3/107); and four, five or six sessions per week (1/107). Fourteen interventions used complex prescriptions such as 2–3 sessions per week, at least 3 sessions per week, 3 sessions per day or had a variable frequency over the course of the programme.

Intensity

Ten different categorisations of prescribing exercise intensity were employed. The most common prescription was a description of claudication pain intensity (28/107). The intensities ranged from the onset of claudication pain to maximal pain. However, the terms used to describe these intensities varied considerably. Terms such as ‘near pain threshold’, ‘till claudication was noted’, ‘moderately severe pain’, ‘submaximal pain’, ‘intense pain’, ‘near max pain’ and ‘unbearable pain’ were used. Two different scales were used to prescribe exercise by the intensity of claudication pain experienced: the ACSM scale which ranges from 1 to 4 (11/107) and the claudication pain scale (14/107) which ranges from 1 to 5. Treadmill tests were used to individually prescribe a treadmill-specific workload in 16/107 interventions. Six interventions prescribed ergometer workloads (cycle or arm) from an ergometer test. Ten interventions prescribed intensity based on rating of perceived exertion and two based on an individual’s heart rate. Seven interventions prescribed resistance exercise via fixed loads, fixed repetition numbers, isokinetic dynamometer-based loads or as a percentage of one repetition maximum. Intensity prescriptions were not clearly specified in 11 interventions with some based on walking a ‘maximum distance’ or walking ‘to tolerance’ if reporting an intensity prescription at all.

Time

The duration of exercise sessions was reported in almost all interventions (102/107) with some interventions prescribing completion of a volume of exercise without an indication of duration. Most interventions prescribed were for a duration of 30–59 min (63/107) or ≥ 60 min (21/107).

Type

Treadmill walking was the most common modality of exercise prescribed (53/107), followed by outdoor/overground walking (19/107), circuit training (8/107), resistance training (6/107), Nordic pole walking (6/107), cycling (5/107) or arm ergometry (3/107). Three interventions did not report the type of exercise prescribed.

Discussion

The aim of this study was to evaluate the quality and completeness of reporting in published exercise interventions for patients with IC which has been defined by the CERT¹⁹ and exercise dose according to the FITT principles. Overall, we identified 107 exercise interventions from 73 studies that adopted a variety of exercise modalities. Our main finding was that in general, the quality of reporting of exercise interventions for patients with IC was poor.

Only 8 out of 19 of the CERT criteria were reported in most interventions. The components that were well reported included the type of equipment used, supervision, a description of the exercises provided, a description of the exercise intervention and whether it was a tailored or generic programme. The highest CERT score was 18/19 which was attained by one intervention which only omitted to describe how fidelity was assessed.⁸⁸ Furthermore, there was no trend to suggest intervention reporting quality had improved over the last 25 years.

The least reported aspect was the use of motivational strategies (question 6), described in only 15% of interventions. Whether this result is artificially low due to a reporting bias is unclear. Investigators may not realise the importance of reporting such strategies, even when they are used. Engaging patients with IC in exercise interventions is challenging, and poor uptake and adherence rates have been noted,¹¹ often because patients desire a ‘quick-fix’ for their symptoms.⁸⁹ Plausibly, the application of known facilitators to exercise behaviour such as goal setting, accessing support systems⁹⁰ or many other potentially effective behaviour change techniques⁹¹ may improve adherence to exercise interventions. That the use of behavioural support strategies is seldom reported limits our understanding of how to promote adherence to exercise in clinical trials and routine care. This problem is compounded by poor reporting of exercise adherence.

The fidelity of, or adherence to, an exercise intervention was reported for only 17% of interventions (question 16a). These results are congruent with those of others using different reporting frameworks.⁹² Intervention fidelity is integral for determining the internal and external validity of intervention-based trials,^93,94 is endorsed by the CONSORT recommendations⁹⁵ and should be reported in all RCTs. This presents a significant potential confounder of pooled analyses of exercise interventions. Different treatment effects might be expected for interventions with 40% versus 80% adherence, but at present, we are largely unable to characterise this effect. Where intervention adherence was described, it was predominantly limited to a description of attendance to exercise sessions. More comprehensive reporting of adherence to an intervention should include a description of the exercise intensity achieved during training and total duration of exercise performed at the prescribed intensity.

Merely recording attendance is not a sufficient measure of intervention fidelity as this assumes that the exercise being performed is of an adequate intensity, type and duration (i.e. dosage) to elicit a benefit. Inadequate measurement and reporting of these components risks efficacious interventions being depicted as ineffective solely because of poor implementation. This could limit the support for this beneficial treatment and contribute to research waste. Such reporting issues have been identified for exercise interventions in hypertension,⁹⁶ breast cancer⁹⁷ and cardiac rehabilitation.⁹⁸ Though exercise intensity was frequently reported (89% of interventions), ten different methods of prescription were used. There is limited consensus on what exercise intensity should be prescribed, with professional societies recommending walking to mild to moderate,⁹⁹ moderate,³ near-maximal¹⁰⁰ and maximal pain.⁷ This heterogeneity, along with poor reporting of adherence, poses a major challenge for between-study comparison of exercise interventions. There is a clear need for standardisation of the prescription and reporting of exercise intensity in this population.

The other principles of exercise prescription include frequency, time and type.¹⁰¹ Clear reporting of these components is vital to allow replication of interventions and translate research knowledge into clinical guidelines for exercise. Of the 107 interventions included in this review, all of them adequately reported the frequency of exercise. Forty-nine prescribed a frequency of three times per week, in line with most current guidance.¹² Time was reported in 102/107 interventions (95%) and was predominantly 30–59 min in duration. Only 3/107 interventions did not describe the type of exercise prescribed. Our results suggest that these components are well reported in the IC literature, though they may not conform to the available clinical guidelines.

Finally, the inclusion of non-exercise components was another poorly reported aspect of exercise interventions. These components may include dietary advice, counselling or patient education with regard to medication adherence or smoking cessation. Only 28% of interventions provided any details of these components, which may plausibly influence treatment outcomes. Again, it is unclear whether these components are underreported or simply absent from most interventions.

Evidently, there is a need to improve reporting quality in this field; at present, there are few tools available to achieve this. The CONSORT checklist is one such tool that has improved the reporting of aspects of RCTs,¹⁰² though more detailed definitions of intervention adherence may be required for complex interventions. Of the 16 (22%) studies that referred to the CONSORT reporting guidance in their manuscripts, only 4 attempted to adhere to this guidance (beyond the inclusion of a CONSORT diagram). No study included in this review made reference to the use of the CERT checklist or the TiDieR checklist. A prudent recommendation would be to require study authors to submit a research checklist as a supplementary material to improve the quality of reporting of exercise interventions in IC populations. The CERT is a comprehensive tool that specifies many important aspects of exercise interventions that should be reported; however, at present, it lacks IC-specific criteria pertaining to the exercise prescription. As such, we recommend that a novel checklist should be developed and trialled to examine the effect of an IC-specific research checklist for exercise interventions.

Limitations

By design, this review has only been able to describe the quality of reporting in the IC literature. It has not been able to investigate reasons for the observed shortcomings in reporting. Some details may be omitted due to word limits or a perceived lack of importance. Whether requiring greater detail in the reporting of exercise interventions in this population will increase the publication of trial protocols or cause the omission of other important information in manuscripts is unknown.

Conclusion

The reporting of exercise interventions in populations with IC is poor. In particular, the reporting of adherence to interventions, strategies to motivate individuals to exercise and non-exercise components of the interventions were rarely reported. Additionally, many different descriptions of exercise intensity were used which will hinder between study comparison. As such, standardisation of the prescription and reporting of exercise intensity in studies including patients with IC is essential. A concerted effort is needed on the part of researchers, reviewers and journal editors to improve the quality of reporting of key aspects of exercise interventions to facilitate the advancement of methodological rigour in this area.

Supplemental Material

sj-pdf-1-vas-10.1177_17085381211070700 – Supplemental Material for A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication

Supplemental Material, sj-pdf-1-vas-10.1177_17085381211070700 for Predictors A systematic review of exercise intervention reporting quality and dose in studies of intermittent claudication by Saïd Ibeggazene, Sean Pymer, Stefan T Birkett, Edward Caldow and Amy E Harwood in Vascular

Footnotes

Author contributions

Conception and design: SI, SP, STB, EC and AEH;

Data extraction: SI, SP, STB, EC and AEH;

Analysis and interpretation of data: SI and AEH;

Draft of article: SI and AEH;

Revision and editing work critically for important intellectual content: SI, SP, STB, EC and AEH.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iDs

Saïd Ibeggazene

Amy E Harwood

Supplemental Material

Supplemental material for this article is available online.

References

Fowkes

FGR

Rudan

, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet 2013; 382(9901): 1329–1340.

Song

Rudan

Zhu

, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019; 7(8): e1020–e1030.

Norgen

Hiatt

Dormandy

, et al. TASC II: Trans-Atlantic inter-society consensus for the management of peripheral arterial disease on behalf of the TASC II working group. Eur J Vasc Endovasc Surg 2007; 33: P1–P2.

Criqui

Fronek

Barrett-Connor

, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71(3): 510–515.

Lane

Harwood

Watson

, et al. Exercise for intermittent claudication. Cochrane Database Syst Rev 2017; 12(12): CD000990.

Aboyans

Ricco

J-B

Bartelink

M-LE

, et al. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS) document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart Journal 2017; 39(9): 763–816.

National Institute for Health and Care Excellence . CG147.1.5 Management of Intermittent Claudication. London: NICE, 2018.

Gerhard-Herman

Gornik

Barrett

, et al. AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2016; 69(11): e71–e126.

Makris

Lattimer

Lavida

, et al. Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovascular Surg 2012; 44(6): 569–575.

10.

Harwood

Pymer

Ibeggazene

, et al. Provision of Exercise Services in Patients with Peripheral Artery Disease in the United Kingdom. Vascular: Online first, 2021.

11.

Harwood

A-E

Smith

Cayton

, et al. A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vas Surg 2016; 34: 280–289.

12.

Harwood

Pymer

Ingle

, et al. Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners. BMJ Open Sport Exerc Med 2020; 6(1): e000897.

13.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 2009; 6(7): e1000097.

14.

Hageman

Fokkenrood

Gommans

, et al. Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 2018; 4(4): CD005263.

15.

Parmenter

Raymond

Dinnen

, et al. A systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis 2011; 218(1): 1–12.

16.

Fakhry

van de Luijtgaarden

Bax

, et al. Supervised walking therapy in patients with intermittent claudication. J Vas Surg 2012; 56(4): 1132–1142.

17.

Vemulapalli

Dolor

Hasselblad

, et al. Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis. Am Heart J 2015; 169(6): 924–937.

18.

Gardner

Poehlman

. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. Jama 1995; 274(12): 975–980.

19.

Slade

Dionne

Underwood

, et al. Consensus on exercise reporting template (CERT): explanation and elaboration statement. Br Journal Sports Medicine 2016; 50(23): 1428–1437.

20.

Crowther

. Effects of a Long Term Exercise Program on Lower Limb Mobility in Peripheral Arterial Disease Patients. Townsville, Australia: James Cook University, 2008.

21.

Allen

Stabler

Kenjale

, et al. Plasma nitrite flux predicts exercise performance in peripheral arterial disease after 3 months of exercise training. Free Radic Biol Med 2010; 49(6): 1138–1144.

22.

Babber

Ravikumar

Onida

, et al. Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial. Br J Surg 2020; 107: 355–363.

23.

Baker

Schenkel

, et al. Effects of exercise training on calf muscle oxygen extraction and blood flow in patients with peripheral artery disease. J Appl Physiol 2017; 123(6): 1599–1609.

24.

Brenner

Brown

Hains

, et al. Low-intensity exercise training increases heart rate variability in patients with peripheral artery disease. Biol Res Nurs 2020; 22(1): 24–33.

25.

Bronas

Treat-Jacobson

Leon

. Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. J Vas Surg 2011; 53(6): 1557–1564.

26.

Cheetham

Burgess

Ellis

, et al. Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial. Eur J Vasc Endovascul Surg 2004; 27(1): 17–23.

27.

Bulińska

Kropielnicka

Jasiński

, et al. Nordic pole walking improves walking capacity in patients with intermittent claudication: a randomized controlled trial. Disabil Rehabil 2016; 38(13): 1318–1324.

28.

Chehuen

Cucato

Carvalho

CRF

, et al. Walking training at the heart rate of pain threshold improves cardiovascular function and autonomic regulation in intermittent claudication: a randomized controlled trial. J Sci Med Sport 2017; 20(10): 886–892.

29.

Christman

. Intervention to Slow Progression of Peripheral Arterial Disease. Dallas, TX, USA: American Heart Association, 2003.

30.

Collins

Langbein

Orebaugh

, et al. PoleStriding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc 2003; 35(3): 384–393.

31.

Collins

Lunos

Carlson

, et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care 2011; 34(10): 2174–2179.

32.

Crowther

Leicht

Spinks

, et al. Effects of a 6-month exercise program pilot study on walking economy, peak physiological characteristics, and walking performance in patients with peripheral arterial disease. Vasc Health Risk Manag 2012; 8: 225.

33.

Cucato

Chehuen

MdR

Costa

LAR

, et al. Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication. Clinics 2013; 68(7): 974–978.

34.

Delaney

Miller

Chataway

, et al. A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and calpain activity in patients with intermittent claudication. Eur J Vasc Endovascul Surg 2014; 47(3): 304–310.

35.

Fakhry

Spronk

van der Laan

, et al. Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial. Jama 2015; 314(18): 1936–1944.

36.

Gardner

Katzel

Sorkin

, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001; 49(6): 755–762.

37.

Gardner

Katzel

Sorkin

, et al. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial. J Cardiopulmonary Rehabil Prev 2002; 22(3): 192–198.

38.

Gardner

Montgomery

Flinn

, et al. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vas Surg 2005; 42(4): 702–709.

39.

Gardner

Parker

Montgomery

, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation 2011; 123(5): 491–498.

40.

Gardner

Montgomery

Parker

. Optimal exercise program length for patients with claudication. J Vas Surg 2012; 55(5): 1346–1354.

41.

Gardner

Parker

Montgomery

, et al. Step‐monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc 2014; 3(5): e001107.

42.

Greenhalgh

. The adjuvant benefit of angioplasty in patients with mild-to-moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for occlusive femoropopliteal and aortoiliac occlusive arterial disease. Eur J Vasc Endovas Surg 2008; 36: 680–688.

43.

Hageman

Fokkenrood

van Deursen

, et al. Randomized controlled trial of vacuum therapy for intermittent claudication. J Vas Surg 2020; 71(5): 1692–1701.

44.

Hobbs

Marshall

Fegan

, et al. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. J Vas Surg 2006; 43(1): 40–46.

45.

Hobbs

Marshall

Fegan

, et al. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial. J Vas Surg 2007; 45(1): 65–70.

46.

Sandercock

Hodges

Das

, et al. The impact of short term supervised and home-based walking programmes on heart rate variability in patients with peripheral arterial disease. J Sports Sci Med 2007; 6(4): 471.

47.

Jones

Skinner

Smith

, et al. Functional improvements following StairMaster vs. treadmill exercise training for patients with intermittent claudication. J Cardiopulm Rehabil Prev 1996; 16(1): 47–55.

48.

Kakkos

Geroulakos

Nicolaides

. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial. Eur J Vas Endovascul Surg 2005; 30(2): 164–175.

49.

Kropielnicka

Dziubek

Bulińska

, et al. Influence of the physical training on muscle function and walking distance in symptomatic peripheral arterial disease in elderly. Biomed Research Intern 2018; 2018.

50.

Lamberti

Malagoni

Ficarra

, et al. Structured home-based exercise versus invasive treatment: A mission impossible? A pilot randomized study in elderly patients with intermittent claudication. Angiology 2016; 67(8): 772–780.

51.

Langbein

Collins

Orebaugh

, et al. Increasing exercise tolerance of persons limited by claudication pain using polestriding. J Vas Surg 2002; 35(5): 887–893.

52.

Leicht

Crowther

Muller

, et al. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. Eur J Vasc Endovascul Surg 2011; 41(4): 511–517.

53.

Maejima

Yasu

Ueba

, et al. Exercise after heparin administration new therapeutic program for patients with non-option arteriosclerosis obliterans. Circ J 2005; 69(9): 1099–1104.

54.

Mays

Hiatt

Casserly

, et al. Community-based walking exercise for peripheral artery disease: An exploratory pilot study. Vasc Med 2015; 20(4): 339–347.

55.

Mazari

Gulati

Rahman

, et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg 2010; 24(1): 69–79.

56.

McGuigan

Bronks

Newton

, et al. Resistance training in patients with peripheral arterial disease: effects on myosin isoforms, fiber type distribution, and capillary supply to skeletal muscle. J Gerontol Ser A Biol Sci Med Sci 2001; 56(7): B302–B310.

57.

Mika

Spodaryk

Cencora

, et al. Red blood cell deformability in patients with claudication after pain-free treadmill training. Clin J Sport Med 2006; 16(4): 335–340.

58.

Mika

Wilk

Mika

, et al. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication. Eur J Cardiovasc Prev Rehabil 2011; 18(5): 754–760.

59.

Mika

Konik

Januszek

, et al. Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardio 2013; 168(2): 838–842.

60.

Murphy

Cutlip

Regensteiner

, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol 2015; 65(10): 999–1009.

61.

Nicolaï

Teijink

Prins

. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg 2010; 52(2): 348–355.

62.

Nordanstig

Taft

Hensäter

, et al. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the invasive revascularization or not in intermittent claudication (IRONIC) trial. Circulation 2014; 130(12): 939–947.

63.

Normahani

Kwasnicki

Bicknell

, et al. Wearable sensor technology efficacy in peripheral vascular disease (wSTEP): a randomized controlled trial. Ann Surg 2018; 268(6): 1113–1118.

64.

Novaković

Krevel

Rajkovič

, et al. Moderate-pain versus pain-free exercise, walking capacity, and cardiovascular health in patients with peripheral artery disease. J Vas Surg 2019; 70(1): 148–156.

65.

Parmenter

Raymond

Dinnen

, et al. High‐intensity progressive resistance training improves flat‐ground walking in older adults with symptomatic peripheral arterial disease. J Am Geriatr Soc 2013; 61(11): 1964–1970.

66.

Parr

Noakes

Derman

. Peripheral arterial disease and intermittent claudication: efficacy of short-term upper body strength training, dynamic exercise training, and advice to exercise at home. South Afr Med J 2009; 99(11): 800–804.

67.

Patterson

Pinto

Marcus

, et al. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997; 25(2): 312–319.

68.

Ramaswami

D’Ayala

Hollier

, et al. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. J Vas Surg 2005; 41(5): 794–801.

69.

Regensteiner

Meyer

Krupski

, et al. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997; 48(4): 291–300.

70.

Sanderson

Askew

Stewart

, et al. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vas Surg 2006; 44(1): 119–127.

71.

Schlager

Giurgea

Schuhfried

, et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis 2011; 217(1): 240–248.

72.

Spafford

Oakley

Beard

. Randomized clinical trial comparing Nordic pole walking and a standard home exercise programme in patients with intermittent claudication. J Br Surg 2014; 101(7): 760–767.

73.

Spronk

Bosch

den Hoed

, et al. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training—randomized controlled trial. Radiology 2009; 250(2): 586–595.

74.

Stewart

Smith

Baird

, et al. Local versus systemic mechanisms underlying supervised exercise training for intermittent claudication. Vasc Endovascul Surg 2008; 42(4): 314–320.

75.

Szymczak

Oszkinis

Majchrzycki

. The impact of walking exercises and resistance training upon the walking distance in patients with chronic lower limb ischaemia. Biomed Res Intern 2016; 2016.

76.

Tebbutt

Robinson

Todhunter

, et al. A plantar flexion device exercise programme for patients with peripheral arterial disease: a randomised prospective feasibility study. Physiotherapy 2011; 97(3): 244–249.

77.

Tew

Nawaz

Zwierska

, et al. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci 2009; 117(12): 405–413.

78.

Tisi

Hulse

Chulakadabba

, et al.

Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response?

Eur J Vasc Endovascul Surg 1997; 14(5): 344–350.

79.

Treat-Jacobson

Bronas

Leon

. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med 2009; 14(3): 203–213.

80.

Tsai

Chan

Wang

C-H

, et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002; 252(5): 448–455.

81.

Van Schaardenburgh

Wohlwend

Rognmo

, et al. Calf raise exercise increases walking performance in patients with intermittent claudication. J Vas Surg 2017; 65(5): 1473–1482.

82.

Villemur

Thoreau

Guinot

, et al. Short interval or continuous training programs to improve walking distance for intermittent claudication: Pilot study. Ann Phys Rehabil Med 2020; 63(6): 466–473.

83.

Wang

Zhou

Bronks

, et al. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease. Clin Rehabil 2007; 21(7): 579–586.

84.

Wang

Zhou

Bronks

, et al. Supervised and home-based exercise training for patients with intermittent claudication. Int J Angiolog Off Pub Int Coll Angiolog Inc 2008; 17(3): 137.

85.

Woessner

VanBruggen

Pieper

, et al. Beet the best? dietary inorganic nitrate to augment exercise training in lower extremity peripheral artery disease with intermittent claudication. Circ Research 2018; 123(6): 654–659.

86.

Zwierska

Walker

Choksy

, et al. Upper-vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vas Surg 2005; 42(6): 1122–1130.

87.

Wood

Sanderson

Askew

, et al. Effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Clin Sci 2006; 111(6): 401–409.

88.

Tew

Humphreys

Crank

, et al. The development and pilot randomised controlled trial of a group education programme for promoting walking in people with intermittent claudication. Vasc Med 2015; 20(4): 348–357.

89.

Popplewell

Bradbury

. Why do health systems not fund supervised exercise programmes for intermittent claudication? Eur J Vas Endovas Surg 2014; 48(6): 608–610.

90.

Abaraogu

Ezenwankwo

Dall

, et al. Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program. PLoS One 2018; 13(7): e0201095.

91.

Michie

Ashford

Sniehotta

, et al. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health 2011; 26(11): 1479–1498.

92.

Tew

Brabyn

Cook

, et al. The completeness of intervention descriptions in randomised trials of supervised exercise training in peripheral arterial disease. PLoS One 2016; 11(3): e0150869.

93.

Bellg

Borrelli

Resnick

, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol 2004; 23(5): 443.

94.

Horner

Rew

Torres

. Enhancing intervention fidelity: a means of strengthening study impact. J Special Pediatr Nurs 2006; 11(2): 80–89.

95.

Schulz

Altman

Moher

, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 2010; 11(1): 32.

96.

Hacke

Nunan

Weisser

. Do exercise trials for hypertension adequately report interventions? A reporting quality study. Int J Sports Med 2018; 39(12): 902–908.

97.

Campbell

Neil

Winters-Stone

. Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med 2012; 46(13): 909–916.

98.

Abell

Glasziou

Hoffmann

. Reporting and replicating trials of exercise-based cardiac rehabilitation: do we know what the researchers actually did? Circ Cardiovasc Qual Outcomes 2015; 8(2): 187–194.

99.

American College of Sports Medicine . ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, 2013.

100.

Conte

Pomposelli

Clair

, et al. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vas Surg 2015; 61(3): 2S–41S.

101.

American College of Sports Medicine . ACSM's Clinical Exercise Physiology. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, 2019.

102.

Turner

Shamseer

Altman

, et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review a. Syst Reviews 2012; 1(1): 60.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.20 MB